PMID- 16490441
OWN - NLM
STAT- MEDLINE
DCOM- 20060418
LR  - 20151119
IS  - 0002-9149 (Print)
IS  - 0002-9149 (Linking)
VI  - 97
IP  - 5
DP  - 2006 Mar 1
TI  - Circadian variation of endothelial function in idiopathic dilated cardiomyopathy.
PG  - 699-702
AB  - This study measured flow-mediated dilation (FMD) of the brachial artery 3 times a 
      day (6:30 a.m., 11:30 a.m., and 9 p.m.) in 7 normal subjects and 14 patients with 
      idiopathic dilated cardiomyopathy (7 in New York Heart Association [NYHA] 
      functional class I or II and 7 in NYHA functional class III or IV). FMD in normal 
      subjects and patients in NYHA class I or II showed a circadian variation, being 
      lowest in the morning and highest at night. Compared with them, FMD in patients 
      in NYHA class III or IV was lower and almost constant during the day, showing 
      loss of significant circadian variation in endothelial function in patients with 
      congestive heart failure.
FAU - Maruo, Takeshi
AU  - Maruo T
AD  - Department of Cardiovascular Medicine, Okayama University Graduate School of 
      Medicine, Okayama, Japan.
FAU - Nakatani, Satoshi
AU  - Nakatani S
FAU - Kanzaki, Hideaki
AU  - Kanzaki H
FAU - Kakuchi, Hiroyuki
AU  - Kakuchi H
FAU - Yamagishi, Masakazu
AU  - Yamagishi M
FAU - Kitakaze, Masafumi
AU  - Kitakaze M
FAU - Ohe, Tohru
AU  - Ohe T
FAU - Miyatake, Kunio
AU  - Miyatake K
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20060109
PL  - United States
TA  - Am J Cardiol
JT  - The American journal of cardiology
JID - 0207277
RN  - 0 (Biomarkers)
RN  - 0 (Vasodilator Agents)
RN  - 114471-18-0 (Natriuretic Peptide, Brain)
RN  - 85637-73-6 (Atrial Natriuretic Factor)
RN  - G59M7S0WS3 (Nitroglycerin)
SB  - IM
MH  - Adult
MH  - Atrial Natriuretic Factor/blood
MH  - Biomarkers/blood
MH  - Blood Flow Velocity
MH  - Brachial Artery/physiopathology
MH  - Cardiomyopathy, Dilated/drug therapy/*physiopathology
MH  - Case-Control Studies
MH  - *Circadian Rhythm/drug effects
MH  - Endothelium, Vascular/drug effects/*physiopathology
MH  - Female
MH  - Forearm/blood supply
MH  - Heart Rate
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Natriuretic Peptide, Brain/blood
MH  - Nitroglycerin/therapeutic use
MH  - Regional Blood Flow
MH  - Stroke Volume
MH  - Treatment Outcome
MH  - Vasodilation/drug effects
MH  - Vasodilator Agents/therapeutic use
EDAT- 2006/02/24 09:00
MHDA- 2006/04/19 09:00
CRDT- 2006/02/24 09:00
PHST- 2005/06/11 00:00 [received]
PHST- 2005/09/09 00:00 [revised]
PHST- 2005/09/09 00:00 [accepted]
PHST- 2006/02/24 09:00 [pubmed]
PHST- 2006/04/19 09:00 [medline]
PHST- 2006/02/24 09:00 [entrez]
AID - S0002-9149(05)02019-9 [pii]
AID - 10.1016/j.amjcard.2005.09.118 [doi]
PST - ppublish
SO  - Am J Cardiol. 2006 Mar 1;97(5):699-702. doi: 10.1016/j.amjcard.2005.09.118. Epub 
      2006 Jan 9.